Cargando…

Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation

BACKGROUND: Fewer Canadian seniors are vaccinated against pneumococcal disease than receive the influenza vaccine annually. Improved understanding of factors influencing pneumococcal vaccination among older adults is needed to improve vaccine uptake. METHODS: A self-administered survey measuring kno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneeberg, Amy, Bettinger, Julie A, McNeil, Shelly, Ward, Brian J, Dionne, Marc, Cooper, Curtis, Coleman, Brenda, Loeb, Mark, Rubinstein, Ethan, McElhaney, Janet, Scheifele, David W, Halperin, Scott A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046143/ https://www.ncbi.nlm.nih.gov/pubmed/24884433 http://dx.doi.org/10.1186/1471-2458-14-442

Ejemplares similares

Efficacy and Safety of CVT-E002, a Proprietary Extract of Panax quinquefolius in the Prevention of Respiratory Infections in Influenza-Vaccinated Community-Dwelling Adults: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial
por: McElhaney, Janet E., et al.
Publicado: (2011)

Immunosenescence Modulation by Vaccination
por: McElhaney, Janet E.
Publicado: (2008)

Immunosenescence Modulation by Vaccination
por: McElhaney, Janet E.
Publicado: (2019)

Vaccines for Improved Cellular Immunity to Influenza
por: Pawelec, Graham, et al.
Publicado: (2018)

Influence of Obesity on Pneumococcus Infection Risk in the Elderly
por: Frasca, Daniela, et al.
Publicado: (2019)

Recent advances in influenza vaccines
por: Pawelec, Graham, et al.
Publicado: (2020)

Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
por: Pawelec, Graham, et al.
Publicado: (2021)

Improving seasonal influenza vaccination for older adults
por: Pawelec, Graham, et al.
Publicado: (2021)

Advancing health equity‐Agency for Healthcare Research and Quality research and action agenda
por: Mistry, Kamila B., et al.
Publicado: (2023)

Postherpetic neuralgia in the elderly
por: Johnson, R W, et al.
Publicado: (2009)

Immunosenescence and Influenza Vaccine Efficacy
por: Sambhara, Suryaprakash, et al.
Publicado: (2009)

The Advanced Research Projects Agency—Health (ARPA-H): a new model for research in child health
por: Varisco, Brian M., et al.
Publicado: (2022)

Frailty Is Associated With Increased Hemagglutination-Inhibition Titers in a 4-Year Randomized Trial Comparing Standard- and High-Dose Influenza Vaccination
por: Loeb, Nathalie, et al.
Publicado: (2020)

2744. A Phase I Randomized, Observer-Blind, Controlled, Dose Escalation Trial of the Safety and Tolerability of a Single Intramuscular Dose of a PAL Adjuvant (Laboratory Code, FB-631) Co-administered with Seasonal TIV (2013–2014) to Healthy Adults ≥18–50 Years of Age
por: Langley, Joanne Marie, et al.
Publicado: (2019)

Age and frailty in COVID-19 vaccine development
por: Andrew, Melissa K, et al.
Publicado: (2021)

One Health collaboration with and among EU Agencies – Bridging research and policy
por: Bronzwaer, Stef, et al.
Publicado: (2022)

Epidemiology of Influenza Viruses in Canada over the 2011–2012 to 2013–2014 Seasons: A Study from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
por: Elsherif, May, et al.
Publicado: (2017)

Immune Biomarkers Predictive of Respiratory Viral Infection in Elderly Nursing Home Residents
por: Johnstone, Jennie, et al.
Publicado: (2014)

International consultation on long-term global health research priorities, research capacity and research uptake in developing countries
por: Conalogue, David Mc, et al.
Publicado: (2017)

Expanding Mental Health Research in India and Providing Funding Agencies— Is the Need of the Hour
por: Porandla, Kishan
Publicado: (2020)

Funding agencies’ complicity in advancing or impeding equity in and through global health research
por: Dixon, J, et al.
Publicado: (2023)

Antibody and Cell-Mediated Immune Responses Are Correlates of Protection against Influenza Infection in Vaccinated Older Adults
por: Verschoor, Chris P., et al.
Publicado: (2021)

Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults
por: Verschoor, Chris P., et al.
Publicado: (2021)

Granzyme B: A Double-Edged Sword in the Response to Influenza Infection in Vaccinated Older Adults
por: Verschoor, Chris P., et al.
Publicado: (2021)

Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults
por: Verschoor, Chris P., et al.
Publicado: (2021)

Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada
por: Langley, Joanne M., et al.
Publicado: (2020)

Symposium of the Establishment of Research Support Agencies
Publicado: (1990)

Independent Agencies and Research Program Performance
por: Keckler, Charles N. W.
Publicado: (2022)

Logics and Agency in Public Management Research
por: Kinder, Tony, et al.
Publicado: (2022)

Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance Network
por: Murad, Yousif, et al.
Publicado: (2022)

992. 2016–2017 Influenza Burden of Disease and End-of-Season Influenza Vaccine Effectiveness (VE) Estimates for Preventing Influenza-Related Hospitalization Among Canadian Adults: An Analysis From the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network
por: Nichols, Michaela, et al.
Publicado: (2018)

Reliable reference genes for the quantification of mRNA in human T-cells and PBMCs stimulated with live influenza virus
por: Roy, Justin G., et al.
Publicado: (2020)

Organisational capacity and its relationship to research use in six Australian health policy agencies
por: Makkar, Steve R., et al.
Publicado: (2018)

Persistent Functional Decline Following Hospitalization with Influenza or Acute Respiratory Illness
por: Andrew, Melissa K., et al.
Publicado: (2020)

Results of a Safety Pooled Analysis of an Adjuvanted Herpes Zoster Subunit Vaccine in More than 14,500 Participants Aged 50 Years or Older
por: López-Fauqued, Marta, et al.
Publicado: (2017)

ENDOCRINES AND THEIR RELATION TO INFLUENZA VIRUS INFECTION
por: Kalter, Seymour S., et al.
Publicado: (1951)

Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection
por: Merani, Shahzma, et al.
Publicado: (2017)

It is necessary to establish an International Agency for Research on Aging
por: Anisimov, Vladimir N., et al.
Publicado: (2018)

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age
por: Langley, Joanne, et al.
Publicado: (2020)

Advanced biological age is associated with improved antibody responses in older high-dose influenza vaccine recipients over four consecutive seasons
por: Verschoor, Chris P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_idjbpqimfs45nhg1pkgs6vsjqm